Four Seasons, Johns Hopkins Partner on Health and Safety Program

Four Seasons New York, which has been accommodating medical workers on the frontline of the COVID-19 pandemic

Four Seasons Hotels and Resorts is collaborating with Johns Hopkins Medicine International to validate its new global health and safety program, Lead With Care, and provide ongoing, real-time guidance on the COVID-19 (coronavirus) situation. To support the development of procedures to be verified by Johns Hopkins, Four Seasons will be working with EcoLab and International SOS.

As part of the collaboration, Johns Hopkins Medicine International and Four Seasons have established a dedicated COVID-19 Advisory Board, bringing together Four Seasons leadership and top experts from Johns Hopkins Medicine International. The COVID-19 Advisory Board will create, enhance and review current procedures, along with virtual and in-person training to guide implementation of Lead With Care across Four Seasons global portfolio.

The Lead With Care program, Four Seasons says, is focused on providing care, confidence and comfort to all guests, employees and residents within the new COVID-19 environment. The new program outlines clear procedures that educate and empower Four Seasons employees to take care of guests and each other. 

FREE Virtual Event

Pivoting Back to Travel: Phase 4

Are you prepared to guide your clients through the “new normal” of travel? Join us December 15, 2020 from 1pm-2:20pm EST for Pivoting Back to Travel: Phase 4. The upcoming installment of our FREE virtual series will feature presentations from the Cayman Islands, Dominican Republic, and Seabourn on their most up-to-date travel procedures, health & safety protocols they’ve implemented to keep guests safe, activities that are open to visitors, what your clients need to know while on their trip and more! Visit www.pivotingbacktotravel to view the full agenda and register for your FREE pass.

Four Seasons collaboration with Johns Hopkins Medicine International will ensure the review and validation of the Lead With Care program in two phases. Phase One of the collaboration (Review and Validation) involves a review of Four Seasons existing health and safety procedures, along with enhanced protocols in response to the current situation at a global, regional and property level. Phase Two (Ongoing Guidance) provides Four Seasons with ongoing collaboration with the Johns Hopkins Medicine International team, including direct access to curated critical updates, relevant COVID-19 research outcomes and expert advice to ensure real-time adjustments to operating procedures. 

Four Seasons and Johns Hopkins will also establish a joint Response Team where senior experts in infectious diseases from Johns Hopkins will provide on-demand response and guidance to hotels facing COVID-19 situations.

While guests will see many of the enhanced Lead With Care procedures, behind-the-scenes measures will also take place through employee training, additional food handling protocols, and enhancements to ventilation systems and other back-of-the-house operations.

In addition, Four Seasons says it continues to invest in its app that further allows guests to control how they engage with others, limiting face-to-face interactions and allowing users to request luggage pickup, airport transfers, room service, restaurant and spa reservations and more.

Related Articles

Ovation Travel Group Creates Amenity Kits for Safer Travels

U.S. Airlines Support TSA Conducting Temperature Screenings

WTTC Debuts Protocols to Rebuild Consumer Confidence

Spice Island Beach Resort Eyes November 1 Reopening

Suggested Articles:

Small-ship luxury Ponant has announced a new "Solar Eclipse" voyage to Antarctica's Weddell Sea during November 2021. Check it out.

Insight Vacations launched its 2021-22 Americas collection, including Alaska, Western, Southern and East Coast U.S., Canada and Latin America.

Laurel Brunvoll of Unforgettable Trips recently returned from a cruise on SeaDream I, which ended early due to guests testing positive for COVID-19.